Abstract
Steroid induced hypertension is well known to be salt and water dependent. In both the clinical and experimental forms of this disorder, salt loading increases while salt deprivation decreases arterial blood pressure [1, 2]. We have previously reported our experience in conscious dogs [3] in which we performed serial quantitative assessment of hemodynamic and volume alterations during sodium deprivation and during gradual replenishment of total body sodium; the aim of the study was to dissociate between the role of sodium and the role of changes of blood and extracellular fluid volumes in the genesis of steroid induced hypertension. The sequence of changes in metyrapone treated dogs (100 mg/kg/day) was compared with untreated controls submitted to the same protocol. Restoration of sodium stores failed to alter arterial blood pressure in untreated dogs while, in contrast, it led to significant hypertension in metyrapone treated dogs. Changes in cardiac output and fluid volumes were virtually identical at every stage in the normotensive and hypertensive dogs. These findings suggested that changes in flow, which occurred in all dogs following salt and water administration, were not responsible for the subsequent rise in arterial pressure. The increased arterial pressure in metyrapone treated dogs was clearly due to a rise in total peripheral resistance when these dogs attained a critical amount of cumulative sodium intake. In fact, these studies have followed a quantitative evaluation of the relationship between sodium intake and total peripheral resistance changes in the presence of excess electrolyte active steroids; increases in cardiac output by as much as 20% were not associated with increased total peripheral resistance or blood pressure when cumulative sodium intake was limited to 140 mEq.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bravo EL, Dustan HP, Tarazi RC (1973): Spironolactone as nonspecific therapy for primary aldosteronism. Circulation 48: 491.
Bravo EL, Tarazi RC, Dustan HP (1977): Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained unanesthetized dogs. Circ Res 40(Suppl I): 1–140.
Onoyama K, Bravo EL, Tarazi RC (1979): Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog. Hypertension 1: 331.
Coleman TG, Grange HJ, Gruyton AC (1971): Whole-body circulatory autoregulation and hypertension. Circ Res 28 & 29(suppl II): 11–76.
deChamplain J, Farley L, Cousineayu D, Van Amerigen MR (1976): Circulating catecholamine levels in human and experimental hypertension. Circ Res 38: 109.
Reid JL, Zivin JA, Kopin IJ (1975): Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res 37: 569.
Schmid PG, Eckstein JW, Abboud FM (1965): Effects of 9-alpha-fluorohydrocortisone on forearm vascular responses to norepinephrine. Circulation 34: 620.
Schmid PH, Eckstein JW, Abboud FM (1967): Effect of 9-alpha-fluorohydrocortisone on forearm venous responses to norepinephrine and tyramine. J Appl Physiol 23: 571.
Overbeck HW, Pamnani MB, Akera T, Brody TM, Haddy FJ (1976): Depressed function of ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res 38(Suppl II): II–48.
Friedman SM (1974): An ion exchange approach to the problem of intracellular sodium in the hypertensive process. Circ Res 34 & 35(suppl I): I–123.
Jones AW, Hart RG (1975): Altered ion transport in aortic smooth muscle during deoxycorticosterone acetate hypertension in the rat. Circ Res 37: 333.
Friedman SM, Friedman CL (1976): Cell permeability, sodium transport and the hypertensive process in the rat. Circ Res 39: 433.
Terris JM, Berecek KH, Cohen EL, Stanley JC, Whitehouse WM Jr, Bohr DF (1976): Deoxycorticosterone hypertension in the pig. Clin Sci Mol Med 51(suppl III): 303.
Conway J, Hatton R (1978): Development of deoxycorticosterone acetate hypertension in the dog. Circ Res 43(Suppl I): I–82.
Berecek KH, Bohr DF (1978): Whole body vascular reactivity during the development of deoxycorticosterone acetate hypertension in the pig. Circ Res 42: 764.
Hinke JAM (1965): In vitro demonstration of vascular hyperresponsiveness in experimental hypertension. Circ Res 17: 359.
Mohring J, Mohring B, Petri M, Haack D (1963): Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol 232: F260.
Haddy FJ, Scott JB, Florio MA, Daugherty RM Jr, Huizinga JN (1963): Local vascular effects of hypokalemia, alkalosis, hypercalcemia and hypomagnesemia. Am J Physiol 204: 202.
Whittam R (1964): Interdependence of metabolism and active transport, in: Hoffman JF (ed), Cellular Functions of Membrane Transport, Section 3, p 139. Englewood Cliffs, N.J.: Prentice-Hall.
Folkow B, Oberg B (1959): The effect of functionally induced changes of wall/lumen ratio on the vasoconstrictor response to standard amounts of vasoactive agents. Acta Physiol Scand 47: 131.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Onoyama, K. (1989). Volume and cardiac factors in the genesis of mineralocorticoid hypertension in the conscious dog. In: Safar, M.E., Fouad-Tarazi, F. (eds) The Heart in Hypertension. Developments in Cardiovascular Medicine, vol 98. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0941-0_15
Download citation
DOI: https://doi.org/10.1007/978-94-009-0941-0_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6913-7
Online ISBN: 978-94-009-0941-0
eBook Packages: Springer Book Archive